title: Industrial update.
abstract: The current industry update covers the period 1-31 August 2014, with the information largely based on company press releases, and news from regulatory agencies, patents and various news websites. On the product approval front, Genzyme, The Medicines Company, Merck, Sharpe & Dohme Corporation, Genentech/Roche, and Boehringer Ingelheim-Eli Lilly reported approval of new products. There was promising news on the clinical trial front for the experimental vaccine to prevent the mosquito-borne viral disease 'chikungunya'. The recent multibillion-dollar deal in the pharma sector is the acquisition of InterMune Inc., a California-based biotech firm, by Roche Holding AG. Also, Cilag GmbH International has announced acquisition of Covagen AG, a privately-held biopharmaceutical company.
authors.affiliation: PolyGen Pharmaceuticals LLC, 41-17 Mercedes Way, Edgewood, NY 11717, USA.
authors.forename: Mayura
authors.initials: M
authors.lastname: Oak
authors.forename: Rhishikesh
authors.initials: R
authors.lastname: Mandke
mesh_terms: D017277:Drug Approval; D004345:Drug Industry